PI3K/AKT/mTOR通路
RPTOR公司
癌变
细胞生物学
蛋白激酶B
mTORC2型
激酶
癌症研究
细胞生长
信号
西罗莫司
mTOR抑制剂的发现与发展
信号转导
生物
癌症
mTORC1型
生物化学
遗传学
作者
Mohamed El‐Tanani,Hamdi Nsairat,Alaa A. A. Aljabali,Ángel Serrano‐Aroca,Vijay Mishra,Yachana Mishra,Gowhar A. Naikoo,Walhan Alshaer,Murtaza M. Tambuwala
出处
期刊:Life Sciences
[Elsevier BV]
日期:2023-04-05
卷期号:323: 121662-121662
被引量:21
标识
DOI:10.1016/j.lfs.2023.121662
摘要
The signalling system known as mammalian target of rapamycin (mTOR) is believed to be required for several biological activities involving cell proliferation. The serine-threonine kinase identified as mTOR recognises PI3K-AKT stress signals. It is well established in the scientific literature that the deregulation of the mTOR pathway plays a crucial role in cancer growth and advancement. This review focuses on the normal functions of mTOR as well as its abnormal roles in cancer development.
科研通智能强力驱动
Strongly Powered by AbleSci AI